Invention Grant
- Patent Title: Anti-vista antibodies and fragments
-
Application No.: US16395585Application Date: 2019-04-26
-
Publication No.: US11242392B2Publication Date: 2022-02-08
- Inventor: Linda Snyder , Gordon Powers
- Applicant: JANSSEN PHARMACEUTICA NV
- Applicant Address: BE Beerse
- Assignee: JANSSEN PHARMACEUTICA NV
- Current Assignee: JANSSEN PHARMACEUTICA NV
- Current Assignee Address: BE Beerse
- Agency: Baker, Donelson, Bearman, Caldwell & Berkowitz PC
- Agent Robin L. Teskin
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; G01N33/574 ; A61K45/06 ; C07K16/30 ; A61K39/00
Abstract:
The present invention relates to novel antibodies and fragments that bind to a V-domain Ig Suppressor of T cell Activation (VISTA), and methods of making and using same. Methods of use include methods of treatment of cancer, including leukemias, lymphomas, solid tumors and melanomas.
Public/Granted literature
- US20200017589A1 ANTI-VISTA ANTIBODIES AND FRAGMENTS Public/Granted day:2020-01-16
Information query
